These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9508191)
1. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. Adachi M; Taki T; Huang C; Higashiyama M; Doi O; Tsuji T; Miyake M J Clin Oncol; 1998 Mar; 16(3):1060-7. PubMed ID: 9508191 [TBL] [Abstract][Full Text] [Related]
2. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216 [TBL] [Abstract][Full Text] [Related]
3. A novel molecular staging protocol for non-small cell lung cancer. Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061 [TBL] [Abstract][Full Text] [Related]
4. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390 [TBL] [Abstract][Full Text] [Related]
5. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043 [TBL] [Abstract][Full Text] [Related]
6. Loss of motility-related protein 1 (MRP1/CD9) and integrin alpha3 expression in endometrial cancers. Miyamoto S; Maruyama A; Okugawa K; Akazawa K; Baba H; Maehara Y; Mekada E Cancer; 2001 Aug; 92(3):542-8. PubMed ID: 11505398 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Higashiyama M; Doi O; Kodama K; Yokouchi H; Adachi M; Huang CL; Taki T; Kasugai T; Ishiguro S; Nakamori S; Miyake M Int J Cancer; 1997 Apr; 74(2):205-11. PubMed ID: 9133457 [TBL] [Abstract][Full Text] [Related]
8. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CD151 gene expression in non-small cell lung cancer. Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509 [TBL] [Abstract][Full Text] [Related]
10. Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Adachi M; Taki T; Higashiyama M; Kohno N; Inufusa H; Miyake M Clin Cancer Res; 2000 Jan; 6(1):96-101. PubMed ID: 10656437 [TBL] [Abstract][Full Text] [Related]
11. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer. Le H; Zeng F; Xu L; Liu X; Huang Y Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
13. CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung. Kwon MS; Shin SH; Yim SH; Lee KY; Kang HM; Kim TM; Chung YJ Lung Cancer; 2007 Jul; 57(1):46-53. PubMed ID: 17350713 [TBL] [Abstract][Full Text] [Related]
14. Integrin laminin receptor profile of pulmonary squamous cell and adenocarcinomas. Patriarca C; Alfano RM; Sonnenberg A; Graziani D; Cassani B; de Melker A; Colombo P; Languino LR; Fornaro M; Warren WH; Coggi G; Gould VE Hum Pathol; 1998 Nov; 29(11):1208-15. PubMed ID: 9824097 [TBL] [Abstract][Full Text] [Related]
15. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509 [TBL] [Abstract][Full Text] [Related]
16. High TBX2 expression predicts poor prognosis in non-small cell lung cancer. Zhang Z; Guo Y Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of TAZ expression in resected non-small cell lung cancer. Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233 [TBL] [Abstract][Full Text] [Related]
18. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Miyake M; Nakano K; Itoi SI; Koh T; Taki T Cancer Res; 1996 Mar; 56(6):1244-9. PubMed ID: 8640807 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [TBL] [Abstract][Full Text] [Related]
20. [Expression of multidrug resistance-associated protein in human non-small cell lung cancer]. Peng X; Feng F; Zhang W Zhonghua Jie He He Hu Xi Za Zhi; 1999 Nov; 22(11):655-8. PubMed ID: 11776518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]